Wolverine Trading’s Evolent Health EVH Stock Holding History

Wolverine Trading’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-38,300	Closed	-$421K	–	5049
2024 Q4	$421K	Buy	38,300 +8,700	+29%	+$153K	﹤0.01%	3596
2024 Q3	$867K	Buy	29,600 +700	+2%	+$18K	﹤0.01%	2498
2024 Q2	$553K	Buy	+28,900	New	+$738K	﹤0.01%	2738
2020 Q1	–	Sell	-43,500	Closed	-$395K	–	4784
2019 Q4	$395K	Buy	43,500 +9,700	+29%	+$78.8K	﹤0.01%	3292
2019 Q3	$245K	Buy	33,800 +6,900	+26%	+$49.5K	﹤0.01%	3367
2019 Q2	$214K	Buy	+26,900	New	+$318K	﹤0.01%	3645
2018 Q4	–	Sell	-18,400	Closed	-$523K	–	4652
2018 Q3	$523K	Buy	18,400 +2,700	+17%	+$64.4K	﹤0.01%	3064
2018 Q2	$224K	Hold	15,700	–	–	﹤0.01%	4220
2018 Q1	$224K	Buy	15,700 +5,700	+57%	+$81.6K	﹤0.01%	4220
2017 Q4	$123K	Buy	+10,000	New	+$141K	﹤0.01%	4377
2017 Q2	–	Sell	-10,700	Closed	-$231K	–	4432
2017 Q1	$231K	Buy	+10,700	New	+$205K	﹤0.01%	3345

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Wolverine Trading's EVH Position: Q1 2025 in Review

Wolverine Trading sold out of Evolent Health (EVH) in Q1 2025, closing a stake of 37,065 shares — an estimated $407K sold.

Wolverine Trading first reported a position in EVH in Q1 2017 and held it in 11 quarters. The position peaked at $456K in Q2 2018. 227 funds tracked by Wall St. Rank hold EVH as of Q1 2025.

Wolverine Trading reported no remaining Evolent Health position as of Q1 2025 after selling out during the quarter.
Wolverine Trading sold 37,065 Evolent Health shares in Q1 2025, an estimated $407K.
Wolverine Trading first reported a position in Evolent Health in Q1 2017 and held it in 11 quarters.
Wolverine Trading's Evolent Health position peaked at $456K in Q2 2018.
227 funds tracked by Wall St. Rank held Evolent Health as of Q1 2025.

Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.